Macerich (NYSE:MAC – Get Free Report) had its price objective reduced by equities researchers at Piper Sandler from $17.00 to $16.00 in a report released on Friday,Benzinga reports. The firm currently has an “underweight” rating on the real estate investment trust’s stock. Piper Sandler’s target price would indicate a potential downside of 11.28% from the company’s current price.
Several other analysts also recently commented on MAC. Compass Point increased their target price on Macerich from $20.00 to $23.00 and gave the company a “buy” rating in a research note on Thursday, November 7th. Mizuho raised Macerich from an “underperform” rating to a “neutral” rating and increased their price target for the company from $14.00 to $22.00 in a report on Wednesday, December 4th. Scotiabank raised Macerich from a “sector underperform” rating to a “sector perform” rating and set a $22.00 price target on the stock in a report on Tuesday, December 17th. Deutsche Bank Aktiengesellschaft assumed coverage on Macerich in a report on Tuesday, December 17th. They set a “hold” rating and a $22.00 price target on the stock. Finally, StockNews.com cut Macerich from a “hold” rating to a “sell” rating in a report on Thursday, November 7th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, Macerich has a consensus rating of “Hold” and a consensus target price of $19.22.
Check Out Our Latest Stock Report on Macerich
Macerich Stock Performance
Insider Buying and Selling
In other Macerich news, Director Andrea M. Stephen sold 63,289 shares of the firm’s stock in a transaction dated Thursday, December 26th. The stock was sold at an average price of $20.59, for a total transaction of $1,303,120.51. Following the sale, the director now directly owns 83,479 shares of the company’s stock, valued at $1,718,832.61. This trade represents a 43.12 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.53% of the stock is owned by insiders.
Institutional Investors Weigh In On Macerich
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Blue Trust Inc. grew its position in shares of Macerich by 152.2% during the third quarter. Blue Trust Inc. now owns 1,546 shares of the real estate investment trust’s stock valued at $28,000 after purchasing an additional 933 shares in the last quarter. International Assets Investment Management LLC grew its position in shares of Macerich by 1,298.4% during the third quarter. International Assets Investment Management LLC now owns 260,598 shares of the real estate investment trust’s stock valued at $4,753,000 after purchasing an additional 241,963 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Macerich by 34.8% during the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,374 shares of the real estate investment trust’s stock valued at $150,000 after purchasing an additional 2,161 shares in the last quarter. DekaBank Deutsche Girozentrale grew its position in shares of Macerich by 5.7% during the third quarter. DekaBank Deutsche Girozentrale now owns 139,352 shares of the real estate investment trust’s stock valued at $2,452,000 after purchasing an additional 7,554 shares in the last quarter. Finally, abrdn plc grew its position in shares of Macerich by 9.2% during the third quarter. abrdn plc now owns 42,971 shares of the real estate investment trust’s stock valued at $784,000 after purchasing an additional 3,636 shares in the last quarter. 87.38% of the stock is owned by institutional investors.
About Macerich
Macerich is a fully integrated, self-managed and self-administered real estate investment trust (REIT). As a leading owner, operator and developer of high-quality retail real estate in densely populated and attractive U.S. markets, Macerich’s portfolio is concentrated in California, the Pacific Northwest, Phoenix/Scottsdale, and the Metro New York to Washington, DC corridor.
Read More
- Five stocks we like better than Macerich
- 3 REITs to Buy and Hold for the Long Term
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- Buy P&G Now, Before It Sets A New All-Time High
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for Macerich Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Macerich and related companies with MarketBeat.com's FREE daily email newsletter.